Rebleeding risk rises with transfusions for patients with NVUGIB

01/31/2013 | Healio

A study published in Alimentary Pharmacology & Therapeutics linked red blood cell transfusions with increased rebleeding risk in patients with nonvariceal upper gastrointestinal bleeding. Transfusions also were associated with greater all-cause mortality. The study of 1,677 patients was limited, according to researchers, but the findings "support the need for a prospective randomized trial."

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA